CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Calmark Sweden AB is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Calmark Sweden AB
Greenhouse Labs, Teknikringen 38A
STOCKHOLM, 114 28  Sweden
Filed for Bankruptcy on 3/7/2024
On 3/7/2024, Calmark Sweden AB filed for Bankruptcy at Karlstad tingsrätt
This company is no longer actively traded on any major stock exchange.
Business Summary
Calmark Sweden AB is a Sweden-based Company providing patient-near-term testing (PNA) specialized in newborns. Its main focus is to develop medical diagnostic biotechnology. The Company focuses on the development of solutions for point-of-care detection of critical illness. Calmark Sweden AB supports physicians and other healthcare professionals to detect illness independently of the cause and regardless of the symptoms.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2022Yes----

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus
8731 Commercial physical and biological research
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board MathiasKarlsson 51 6/13/2023
Chief Executive Officer AnnaSoderlund 6/15/2023 1/1/2016
Interim Chief Financial Officer Klas PeterLarsson 59 11/14/2022 11/14/2022
9 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 112,964,590 (As of 12/31/2023)
Stock Exchange: AKT


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024